Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.
RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
Award recipients to use IRIS Registry database to conduct population-based studies.
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
RPB celebrates five decades of sight-saving discoveries at NEI.
RPB hosted its fifth annual convening of organizations that fund vision research in Washington DC.
Partnership to utilize IRIS Registry database to advance patient care.
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|